nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ALB—Auranofin—psoriatic arthritis	0.158	0.167	CbGbCtD
Mirabegron—BCHE—Triamcinolone—psoriatic arthritis	0.13	0.137	CbGbCtD
Mirabegron—SLCO1A2—Prednisolone—psoriatic arthritis	0.103	0.109	CbGbCtD
Mirabegron—SLCO1A2—Prednisone—psoriatic arthritis	0.0974	0.103	CbGbCtD
Mirabegron—SLCO1A2—Dexamethasone—psoriatic arthritis	0.0608	0.0641	CbGbCtD
Mirabegron—ALB—Prednisone—psoriatic arthritis	0.0503	0.053	CbGbCtD
Mirabegron—SLCO1A2—Methotrexate—psoriatic arthritis	0.0488	0.0515	CbGbCtD
Mirabegron—ABCB1—Methylprednisolone—psoriatic arthritis	0.0434	0.0458	CbGbCtD
Mirabegron—ABCB1—Betamethasone—psoriatic arthritis	0.0282	0.0298	CbGbCtD
Mirabegron—ABCB1—Prednisolone—psoriatic arthritis	0.0279	0.0294	CbGbCtD
Mirabegron—ABCB1—Prednisone—psoriatic arthritis	0.0263	0.0277	CbGbCtD
Mirabegron—CYP3A4—Methylprednisolone—psoriatic arthritis	0.026	0.0274	CbGbCtD
Mirabegron—ALB—Methotrexate—psoriatic arthritis	0.0252	0.0266	CbGbCtD
Mirabegron—CYP3A4—Triamcinolone—psoriatic arthritis	0.0197	0.0208	CbGbCtD
Mirabegron—CYP3A4—Betamethasone—psoriatic arthritis	0.0169	0.0178	CbGbCtD
Mirabegron—CYP3A4—Prednisolone—psoriatic arthritis	0.0167	0.0176	CbGbCtD
Mirabegron—ABCB1—Dexamethasone—psoriatic arthritis	0.0164	0.0173	CbGbCtD
Mirabegron—CYP3A4—Prednisone—psoriatic arthritis	0.0158	0.0166	CbGbCtD
Mirabegron—CYP2D6—Dexamethasone—psoriatic arthritis	0.0155	0.0163	CbGbCtD
Mirabegron—ABCB1—Methotrexate—psoriatic arthritis	0.0132	0.0139	CbGbCtD
Mirabegron—CYP3A4—Dexamethasone—psoriatic arthritis	0.00984	0.0104	CbGbCtD
Mirabegron—Eye disorder—Auranofin—psoriatic arthritis	0.00105	0.0205	CcSEcCtD
Mirabegron—Glaucoma—Prednisolone—psoriatic arthritis	0.000945	0.0185	CcSEcCtD
Mirabegron—Leukocytoclastic vasculitis—Methotrexate—psoriatic arthritis	0.000881	0.0172	CcSEcCtD
Mirabegron—Glaucoma—Triamcinolone—psoriatic arthritis	0.000869	0.017	CcSEcCtD
Mirabegron—Glaucoma—Methylprednisolone—psoriatic arthritis	0.000867	0.017	CcSEcCtD
Mirabegron—Glaucoma—Dexamethasone—psoriatic arthritis	0.000789	0.0154	CcSEcCtD
Mirabegron—Glaucoma—Betamethasone—psoriatic arthritis	0.000789	0.0154	CcSEcCtD
Mirabegron—Dyspepsia—Auranofin—psoriatic arthritis	0.000701	0.0137	CcSEcCtD
Mirabegron—Glaucoma—Prednisone—psoriatic arthritis	0.000687	0.0134	CcSEcCtD
Mirabegron—Constipation—Auranofin—psoriatic arthritis	0.000681	0.0133	CcSEcCtD
Mirabegron—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.000651	0.0127	CcSEcCtD
Mirabegron—Urticaria—Auranofin—psoriatic arthritis	0.000633	0.0124	CcSEcCtD
Mirabegron—Abdominal pain—Auranofin—psoriatic arthritis	0.000629	0.0123	CcSEcCtD
Mirabegron—Pruritus—Auranofin—psoriatic arthritis	0.000563	0.011	CcSEcCtD
Mirabegron—Dry eye—Betamethasone—psoriatic arthritis	0.000548	0.0107	CcSEcCtD
Mirabegron—Dry eye—Dexamethasone—psoriatic arthritis	0.000548	0.0107	CcSEcCtD
Mirabegron—Diarrhoea—Auranofin—psoriatic arthritis	0.000545	0.0107	CcSEcCtD
Mirabegron—Vascular purpura—Triamcinolone—psoriatic arthritis	0.000531	0.0104	CcSEcCtD
Mirabegron—Osteoarthritis—Prednisolone—psoriatic arthritis	0.000517	0.0101	CcSEcCtD
Mirabegron—Rash—Auranofin—psoriatic arthritis	0.000502	0.00982	CcSEcCtD
Mirabegron—Dermatitis—Auranofin—psoriatic arthritis	0.000502	0.00981	CcSEcCtD
Mirabegron—Purpura—Triamcinolone—psoriatic arthritis	0.000493	0.00964	CcSEcCtD
Mirabegron—Osteoarthritis—Triamcinolone—psoriatic arthritis	0.000475	0.00929	CcSEcCtD
Mirabegron—Osteoarthritis—Methylprednisolone—psoriatic arthritis	0.000474	0.00927	CcSEcCtD
Mirabegron—Nausea—Auranofin—psoriatic arthritis	0.000473	0.00925	CcSEcCtD
Mirabegron—Abdominal distension—Prednisolone—psoriatic arthritis	0.000449	0.00879	CcSEcCtD
Mirabegron—Osteoarthritis—Betamethasone—psoriatic arthritis	0.000431	0.00843	CcSEcCtD
Mirabegron—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.000431	0.00843	CcSEcCtD
Mirabegron—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000428	0.00838	CcSEcCtD
Mirabegron—Cystitis noninfective—Methotrexate—psoriatic arthritis	0.000422	0.00826	CcSEcCtD
Mirabegron—Vascular purpura—Prednisone—psoriatic arthritis	0.00042	0.00821	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.000418	0.00818	CcSEcCtD
Mirabegron—Cystitis—Methotrexate—psoriatic arthritis	0.000417	0.00816	CcSEcCtD
Mirabegron—Abdominal distension—Triamcinolone—psoriatic arthritis	0.000413	0.00808	CcSEcCtD
Mirabegron—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.000412	0.00807	CcSEcCtD
Mirabegron—Influenza—Triamcinolone—psoriatic arthritis	0.000411	0.00803	CcSEcCtD
Mirabegron—Vaginal infection—Methotrexate—psoriatic arthritis	0.000408	0.00798	CcSEcCtD
Mirabegron—Neoplasm—Methotrexate—psoriatic arthritis	0.000391	0.00764	CcSEcCtD
Mirabegron—Bladder pain—Methotrexate—psoriatic arthritis	0.000391	0.00764	CcSEcCtD
Mirabegron—Purpura—Prednisone—psoriatic arthritis	0.000389	0.00762	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.000382	0.00746	CcSEcCtD
Mirabegron—Osteoarthritis—Prednisone—psoriatic arthritis	0.000375	0.00734	CcSEcCtD
Mirabegron—Infestation—Methylprednisolone—psoriatic arthritis	0.000365	0.00714	CcSEcCtD
Mirabegron—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000365	0.00714	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000331	0.00648	CcSEcCtD
Mirabegron—Rhinitis—Triamcinolone—psoriatic arthritis	0.000329	0.00644	CcSEcCtD
Mirabegron—Rhinitis—Methylprednisolone—psoriatic arthritis	0.000329	0.00643	CcSEcCtD
Mirabegron—Abdominal distension—Prednisone—psoriatic arthritis	0.000327	0.00639	CcSEcCtD
Mirabegron—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000322	0.0063	CcSEcCtD
Mirabegron—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00032	0.00626	CcSEcCtD
Mirabegron—Osteoarthritis—Methotrexate—psoriatic arthritis	0.000314	0.00614	CcSEcCtD
Mirabegron—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000306	0.00599	CcSEcCtD
Mirabegron—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000304	0.00595	CcSEcCtD
Mirabegron—Vision blurred—Prednisolone—psoriatic arthritis	0.000293	0.00573	CcSEcCtD
Mirabegron—Breast disorder—Methotrexate—psoriatic arthritis	0.000283	0.00554	CcSEcCtD
Mirabegron—Eye disorder—Dexamethasone—psoriatic arthritis	0.000279	0.00545	CcSEcCtD
Mirabegron—Eye disorder—Betamethasone—psoriatic arthritis	0.000279	0.00545	CcSEcCtD
Mirabegron—Back pain—Triamcinolone—psoriatic arthritis	0.000277	0.00541	CcSEcCtD
Mirabegron—Hypertension—Prednisolone—psoriatic arthritis	0.000269	0.00525	CcSEcCtD
Mirabegron—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000255	0.00499	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000252	0.00493	CcSEcCtD
Mirabegron—Tachycardia—Prednisolone—psoriatic arthritis	0.000248	0.00485	CcSEcCtD
Mirabegron—Hypertension—Triamcinolone—psoriatic arthritis	0.000247	0.00483	CcSEcCtD
Mirabegron—Hypertension—Methylprednisolone—psoriatic arthritis	0.000246	0.00482	CcSEcCtD
Mirabegron—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000243	0.00475	CcSEcCtD
Mirabegron—Eye disorder—Prednisone—psoriatic arthritis	0.000243	0.00475	CcSEcCtD
Mirabegron—Infestation—Methotrexate—psoriatic arthritis	0.000242	0.00473	CcSEcCtD
Mirabegron—Infestation NOS—Methotrexate—psoriatic arthritis	0.000242	0.00473	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000241	0.00472	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00024	0.00469	CcSEcCtD
Mirabegron—Dry mouth—Triamcinolone—psoriatic arthritis	0.000238	0.00466	CcSEcCtD
Mirabegron—Infection—Triamcinolone—psoriatic arthritis	0.000232	0.00454	CcSEcCtD
Mirabegron—Infection—Methylprednisolone—psoriatic arthritis	0.000231	0.00453	CcSEcCtD
Mirabegron—Tachycardia—Triamcinolone—psoriatic arthritis	0.000228	0.00446	CcSEcCtD
Mirabegron—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000227	0.00445	CcSEcCtD
Mirabegron—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000226	0.00443	CcSEcCtD
Mirabegron—Hypertension—Dexamethasone—psoriatic arthritis	0.000224	0.00438	CcSEcCtD
Mirabegron—Hypertension—Betamethasone—psoriatic arthritis	0.000224	0.00438	CcSEcCtD
Mirabegron—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000214	0.00419	CcSEcCtD
Mirabegron—Vision blurred—Prednisone—psoriatic arthritis	0.000213	0.00417	CcSEcCtD
Mirabegron—Urethral disorder—Methotrexate—psoriatic arthritis	0.000213	0.00416	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000213	0.00416	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000212	0.00415	CcSEcCtD
Mirabegron—Infection—Betamethasone—psoriatic arthritis	0.00021	0.00412	CcSEcCtD
Mirabegron—Infection—Dexamethasone—psoriatic arthritis	0.00021	0.00412	CcSEcCtD
Mirabegron—Tachycardia—Betamethasone—psoriatic arthritis	0.000207	0.00404	CcSEcCtD
Mirabegron—Tachycardia—Dexamethasone—psoriatic arthritis	0.000207	0.00404	CcSEcCtD
Mirabegron—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000206	0.00402	CcSEcCtD
Mirabegron—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000205	0.00401	CcSEcCtD
Mirabegron—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000205	0.00401	CcSEcCtD
Mirabegron—Eye disorder—Methotrexate—psoriatic arthritis	0.000203	0.00397	CcSEcCtD
Mirabegron—Urticaria—Prednisolone—psoriatic arthritis	0.000202	0.00394	CcSEcCtD
Mirabegron—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000201	0.00394	CcSEcCtD
Mirabegron—Fatigue—Triamcinolone—psoriatic arthritis	0.000201	0.00394	CcSEcCtD
Mirabegron—Fatigue—Methylprednisolone—psoriatic arthritis	0.000201	0.00393	CcSEcCtD
Mirabegron—Hypertension—Prednisone—psoriatic arthritis	0.000195	0.00382	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000193	0.00378	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000193	0.00378	CcSEcCtD
Mirabegron—Arthralgia—Prednisone—psoriatic arthritis	0.000192	0.00376	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000191	0.00374	CcSEcCtD
Mirabegron—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00019	0.00373	CcSEcCtD
Mirabegron—Dyspepsia—Betamethasone—psoriatic arthritis	0.000186	0.00365	CcSEcCtD
Mirabegron—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000186	0.00365	CcSEcCtD
Mirabegron—Urticaria—Triamcinolone—psoriatic arthritis	0.000185	0.00363	CcSEcCtD
Mirabegron—Urticaria—Methylprednisolone—psoriatic arthritis	0.000185	0.00362	CcSEcCtD
Mirabegron—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000184	0.0036	CcSEcCtD
Mirabegron—Infection—Prednisone—psoriatic arthritis	0.000183	0.00358	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000183	0.00358	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000183	0.00358	CcSEcCtD
Mirabegron—Back pain—Methotrexate—psoriatic arthritis	0.000183	0.00357	CcSEcCtD
Mirabegron—Fatigue—Dexamethasone—psoriatic arthritis	0.000183	0.00357	CcSEcCtD
Mirabegron—Fatigue—Betamethasone—psoriatic arthritis	0.000183	0.00357	CcSEcCtD
Mirabegron—Tachycardia—Prednisone—psoriatic arthritis	0.00018	0.00352	CcSEcCtD
Mirabegron—Skin disorder—Prednisone—psoriatic arthritis	0.000179	0.0035	CcSEcCtD
Mirabegron—Vision blurred—Methotrexate—psoriatic arthritis	0.000178	0.00348	CcSEcCtD
Mirabegron—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000173	0.00339	CcSEcCtD
Mirabegron—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000173	0.00339	CcSEcCtD
Mirabegron—Urticaria—Betamethasone—psoriatic arthritis	0.000168	0.00329	CcSEcCtD
Mirabegron—Urticaria—Dexamethasone—psoriatic arthritis	0.000168	0.00329	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000168	0.00329	CcSEcCtD
Mirabegron—Dizziness—Prednisolone—psoriatic arthritis	0.000168	0.00328	CcSEcCtD
Mirabegron—Asthenia—Triamcinolone—psoriatic arthritis	0.000168	0.00328	CcSEcCtD
Mirabegron—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000167	0.00328	CcSEcCtD
Mirabegron—Abdominal pain—Betamethasone—psoriatic arthritis	0.000167	0.00328	CcSEcCtD
Mirabegron—Asthenia—Methylprednisolone—psoriatic arthritis	0.000167	0.00327	CcSEcCtD
Mirabegron—Pruritus—Triamcinolone—psoriatic arthritis	0.000165	0.00323	CcSEcCtD
Mirabegron—Pruritus—Methylprednisolone—psoriatic arthritis	0.000165	0.00322	CcSEcCtD
Mirabegron—Dyspepsia—Prednisone—psoriatic arthritis	0.000162	0.00318	CcSEcCtD
Mirabegron—Arthralgia—Methotrexate—psoriatic arthritis	0.000161	0.00315	CcSEcCtD
Mirabegron—Rash—Prednisolone—psoriatic arthritis	0.00016	0.00313	CcSEcCtD
Mirabegron—Dermatitis—Prednisolone—psoriatic arthritis	0.00016	0.00313	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00016	0.00312	CcSEcCtD
Mirabegron—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000159	0.00312	CcSEcCtD
Mirabegron—Fatigue—Prednisone—psoriatic arthritis	0.000159	0.00311	CcSEcCtD
Mirabegron—Headache—Prednisolone—psoriatic arthritis	0.000159	0.00311	CcSEcCtD
Mirabegron—Constipation—Prednisone—psoriatic arthritis	0.000158	0.00309	CcSEcCtD
Mirabegron—Dizziness—Triamcinolone—psoriatic arthritis	0.000154	0.00302	CcSEcCtD
Mirabegron—Dizziness—Methylprednisolone—psoriatic arthritis	0.000154	0.00301	CcSEcCtD
Mirabegron—Infection—Methotrexate—psoriatic arthritis	0.000153	0.003	CcSEcCtD
Mirabegron—Asthenia—Betamethasone—psoriatic arthritis	0.000152	0.00297	CcSEcCtD
Mirabegron—Asthenia—Dexamethasone—psoriatic arthritis	0.000152	0.00297	CcSEcCtD
Mirabegron—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000151	0.00295	CcSEcCtD
Mirabegron—Nausea—Prednisolone—psoriatic arthritis	0.000151	0.00295	CcSEcCtD
Mirabegron—Pruritus—Dexamethasone—psoriatic arthritis	0.00015	0.00293	CcSEcCtD
Mirabegron—Pruritus—Betamethasone—psoriatic arthritis	0.00015	0.00293	CcSEcCtD
Mirabegron—Skin disorder—Methotrexate—psoriatic arthritis	0.00015	0.00293	CcSEcCtD
Mirabegron—Rash—Triamcinolone—psoriatic arthritis	0.000147	0.00288	CcSEcCtD
Mirabegron—Dermatitis—Triamcinolone—psoriatic arthritis	0.000147	0.00288	CcSEcCtD
Mirabegron—Rash—Methylprednisolone—psoriatic arthritis	0.000147	0.00287	CcSEcCtD
Mirabegron—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000147	0.00287	CcSEcCtD
Mirabegron—Urticaria—Prednisone—psoriatic arthritis	0.000147	0.00287	CcSEcCtD
Mirabegron—Headache—Triamcinolone—psoriatic arthritis	0.000146	0.00286	CcSEcCtD
Mirabegron—Headache—Methylprednisolone—psoriatic arthritis	0.000146	0.00285	CcSEcCtD
Mirabegron—Abdominal pain—Prednisone—psoriatic arthritis	0.000146	0.00285	CcSEcCtD
Mirabegron—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000145	0.00284	CcSEcCtD
Mirabegron—Diarrhoea—Betamethasone—psoriatic arthritis	0.000145	0.00284	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00014	0.00275	CcSEcCtD
Mirabegron—Dizziness—Dexamethasone—psoriatic arthritis	0.00014	0.00274	CcSEcCtD
Mirabegron—Dizziness—Betamethasone—psoriatic arthritis	0.00014	0.00274	CcSEcCtD
Mirabegron—Nausea—Triamcinolone—psoriatic arthritis	0.000139	0.00271	CcSEcCtD
Mirabegron—Nausea—Methylprednisolone—psoriatic arthritis	0.000138	0.00271	CcSEcCtD
Mirabegron—Dyspepsia—Methotrexate—psoriatic arthritis	0.000136	0.00265	CcSEcCtD
Mirabegron—Rash—Betamethasone—psoriatic arthritis	0.000134	0.00261	CcSEcCtD
Mirabegron—Rash—Dexamethasone—psoriatic arthritis	0.000134	0.00261	CcSEcCtD
Mirabegron—Dermatitis—Dexamethasone—psoriatic arthritis	0.000133	0.00261	CcSEcCtD
Mirabegron—Dermatitis—Betamethasone—psoriatic arthritis	0.000133	0.00261	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000133	0.0026	CcSEcCtD
Mirabegron—Fatigue—Methotrexate—psoriatic arthritis	0.000133	0.0026	CcSEcCtD
Mirabegron—Headache—Dexamethasone—psoriatic arthritis	0.000133	0.0026	CcSEcCtD
Mirabegron—Headache—Betamethasone—psoriatic arthritis	0.000133	0.0026	CcSEcCtD
Mirabegron—Asthenia—Prednisone—psoriatic arthritis	0.000132	0.00259	CcSEcCtD
Mirabegron—Pruritus—Prednisone—psoriatic arthritis	0.000131	0.00255	CcSEcCtD
Mirabegron—Diarrhoea—Prednisone—psoriatic arthritis	0.000126	0.00247	CcSEcCtD
Mirabegron—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000126	0.00247	CcSEcCtD
Mirabegron—Nausea—Betamethasone—psoriatic arthritis	0.000126	0.00246	CcSEcCtD
Mirabegron—Nausea—Dexamethasone—psoriatic arthritis	0.000126	0.00246	CcSEcCtD
Mirabegron—Urticaria—Methotrexate—psoriatic arthritis	0.000122	0.0024	CcSEcCtD
Mirabegron—Dizziness—Prednisone—psoriatic arthritis	0.000122	0.00239	CcSEcCtD
Mirabegron—Abdominal pain—Methotrexate—psoriatic arthritis	0.000122	0.00238	CcSEcCtD
Mirabegron—Rash—Prednisone—psoriatic arthritis	0.000116	0.00228	CcSEcCtD
Mirabegron—Dermatitis—Prednisone—psoriatic arthritis	0.000116	0.00227	CcSEcCtD
Mirabegron—Headache—Prednisone—psoriatic arthritis	0.000116	0.00226	CcSEcCtD
Mirabegron—Asthenia—Methotrexate—psoriatic arthritis	0.000111	0.00216	CcSEcCtD
Mirabegron—Nausea—Prednisone—psoriatic arthritis	0.00011	0.00214	CcSEcCtD
Mirabegron—Pruritus—Methotrexate—psoriatic arthritis	0.000109	0.00213	CcSEcCtD
Mirabegron—Diarrhoea—Methotrexate—psoriatic arthritis	0.000105	0.00206	CcSEcCtD
Mirabegron—Dizziness—Methotrexate—psoriatic arthritis	0.000102	0.00199	CcSEcCtD
Mirabegron—Rash—Methotrexate—psoriatic arthritis	9.72e-05	0.0019	CcSEcCtD
Mirabegron—Dermatitis—Methotrexate—psoriatic arthritis	9.71e-05	0.0019	CcSEcCtD
Mirabegron—Headache—Methotrexate—psoriatic arthritis	9.66e-05	0.00189	CcSEcCtD
Mirabegron—Nausea—Methotrexate—psoriatic arthritis	9.16e-05	0.00179	CcSEcCtD
